Literature DB >> 10556920

Modulation by protease-activated receptors of the rat duodenal motility in vitro: possible mechanisms underlying the evoked contraction and relaxation.

A Kawabata1, R Kuroda, H Nishikawa, K Kawai.   

Abstract

1 The present study examined effects of agonist enzymes and receptor-activating peptides for protease-activated receptors (PARs) on duodenal motility in the rat, and also investigated possible mechanisms underlying the evoked responses. 2 Thrombin at 0.03-0.1 microM and the PAR-1-activating peptide SFLLR-NH2 at 3-100 microM or TFLLR-NH2 at 10-50 microM produced a dual action, relaxation followed by contraction of the duodenal longitudinal muscle. The PAR-2-activating peptide SLIGRL-NH2 at 10-100 microM elicited only small contraction. Trypsin at 0.08 microM induced small contraction, or relaxation followed by contraction, depending on preparations. The PAR-4-activating peptide GYPGKF-NH2 at 1000 microM exhibited no effect. 3 The contractile responses of the duodenal strips to TFLLR-NH2 and to SLIGRL-NH2 were partially attenuated by the L-type calcium channel blocker nifedipine (1 microM), the protein kinase C inhibitor GF109203X (1 microM) and the tyrosine kinase inhibitor genistein (15 microM), but were resistant to indomethacin (3 microM) and tetrodotoxin (1-10 microM). 4 The relaxation of the preparations exerted by TFLLR-NH2 was unaffected by indomethacin (3 microM), propranolol (5 microM), NG-nitro-L-arginine methyl ester (100 microM) and tetrodotoxin (1-10 microM). This relaxation was resistant to either GF109203X (1 microM) or genistein (15 microM), but was, remarkably, attenuated by combined application of these two kinase inhibitors. 5 Apamin (0.1 microM), an inhibitor of calcium-activated, small-conductance potassium channels, but not charybdotoxin (0.1 microM), completely abolished the PAR-1-mediated duodenal relaxation, and significantly enhanced the PAR-1-mediated contraction. 6 These findings demonstrate that PAR-1 plays a dual role, suppression and facilitation of smooth muscle motility in the rat duodenum, while PAR-2 plays a minor excitatory role in the muscle, and that PAR-4 is not involved in the duodenal tension modulation. The results also suggest that the contractile responses to PAR-1 and PAR-2 activation are mediated, in part, by activation of L-type calcium channels, protein kinase C and tyrosine kinase, and that the relaxation response to PAR-1 activation occurs via activation of apamin-sensitive, but charybdotoxin-insensitive, potassium channels, in which both protein kinase C and tyrosine kinase might be involved synergistically.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556920      PMCID: PMC1571701          DOI: 10.1038/sj.bjp.0702755

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

Authors:  T K Vu; D T Hung; V I Wheaton; S R Coughlin
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

2.  Molecular cloning of a potential proteinase activated receptor.

Authors:  S Nystedt; K Emilsson; C Wahlestedt; J Sundelin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

3.  Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue.

Authors:  M Saifeddine; B al-Ani; C H Cheng; L Wang; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

4.  Interactions of mast cell tryptase with thrombin receptors and PAR-2.

Authors:  M Molino; E S Barnathan; R Numerof; J Clark; M Dreyer; A Cumashi; J A Hoxie; N Schechter; M Woolkalis; L F Brass
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

5.  Protease-activated receptor 3 is a second thrombin receptor in humans.

Authors:  H Ishihara; A J Connolly; D Zeng; M L Kahn; Y W Zheng; C Timmons; T Tram; S R Coughlin
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

6.  Enhancement of vascular permeability by specific activation of protease-activated receptor-1 in rat hindpaw: a protective role of endogenous and exogenous nitric oxide.

Authors:  A Kawabata; R Kuroda; H Nishikawa; T Asai; K Kataoka; M Taneda
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

7.  Metabolic stress opens K+ channels in hepatoma cells through a Ca2+- and protein kinase calpha-dependent mechanism.

Authors:  Y Wang; A Sostman; R Roman; S Stribling; S Vigna; Y Hannun; J Raymond; J G Fitz
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

8.  Vascular actions of thrombin receptor-derived polypeptides: structure-activity profiles for contractile and relaxant effects in rat aorta.

Authors:  A A Laniyonu; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

9.  Modulation by nitric oxide of spontaneous motility of the rat isolated duodenum: role of tachykinins.

Authors:  M A Martinez-Cuesta; J V Esplugues; B J Whittle
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

10.  Thrombin functions as an inflammatory mediator through activation of its receptor.

Authors:  G Cirino; C Cicala; M R Bucci; L Sorrentino; J M Maraganore; S R Stone
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Protease-activated receptor 4: a critical participator in inflammatory response.

Authors:  Qiang Fu; Jing Cheng; Yebo Gao; Yonglei Zhang; Xiaobing Chen; Jianguo Xie
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

2.  The functional role of protease-activated receptors on contractile responses by activation of Ca2+ sensitization pathways in simian colonic muscles.

Authors:  Tae Sik Sung; Hongli Lu; Juno Sung; Jong Hoon Yeom; Brian A Perrino; Sang Don Koh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-09-27       Impact factor: 4.052

3.  The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection.

Authors:  A Kawabata; M Kinoshita; H Nishikawa; R Kuroda; M Nishida; H Araki; N Arizono; Y Oda; K Kakehi
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

4.  In vivo evidence that protease-activated receptors 1 and 2 modulate gastrointestinal transit in the mouse.

Authors:  A Kawabata; R Kuroda; N Nagata; N Kawao; T Masuko; H Nishikawa; K Kawai
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

5.  Protease-activated receptor (PAR)1, PAR2 and PAR4 expressions in esophageal squamous cell carcinoma.

Authors:  Si-Man Li; Ping Jiang; Yang Xiang; Wei-Wei Wang; Yue-Chun Zhu; Wei-Yang Feng; Shu-De Li; Guo-Yu Yu
Journal:  Dongwuxue Yanjiu       Date:  2014-09

Review 6.  Gastrointestinal roles for proteinase-activated receptors in health and disease.

Authors:  A Kawabata; M Matsunami; F Sekiguchi
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

7.  Mechanism of trypsin-induced endothelium-dependent vasorelaxation in the porcine coronary artery.

Authors:  T Nakayama; K Hirano; J Nishimura; S Takahashi; H Kanaide
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

8.  Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo.

Authors:  T Kanke; M Kabeya; S Kubo; S Kondo; K Yasuoka; J Tagashira; H Ishiwata; M Saka; T Furuyama; T Nishiyama; T Doi; Y Hattori; A Kawabata; M R Cunningham; R Plevin
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

9.  Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon.

Authors:  F Mulè; R Pizzuti; A Capparelli; N Vergnolle
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

10.  Involvement of nitric oxide and tachykinins in the effects induced by protease-activated receptors in rat colon longitudinal muscle.

Authors:  Flavia Mulè; Maria Carmela Baffi; Anna Capparelli; Roberta Pizzuti
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.